Resistance of human ovarian cancer cells to tumor necrosis factor α is a consequence of nuclear factor κB-mediated induction of Fas-associated death domain-like interleukin-1β-converting enzyme-like inhibitory protein

Endocrinology

Volumn 144, Issue 2, 2003, Pages 623-630

  Xiao, Chao Wu ^a,b   Yan, Xiaojuan ^a   Li, Yulian ^a   Reddy, Shrikanth A G ^c   Tsang, Benjamin K ^a,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HEALTH CANADA   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CASPASE 3; CASPASE 8; COMPLEMENTARY DNA; CYCLOHEXIMIDE; CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LINEAGE; CONTROLLED STUDY; DRUG RESISTANCE; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA ANALYSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 1; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CYCLOHEXIMIDE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; OVARIAN NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0037320340     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2001-211024     Document Type: Article

References (64)

1. Andreani CL, Payne DW, Packman JN, Resnick CE, Hurwitz A, Adashi EY 1991 Cytokine-mediated regulation of ovarian function. Tumor necrosis factor α inhibits gonadotropin-supported ovarian androgen biosynthesis. J Biol Chem 266:6761-6766
2. Baker SJ, Reddy EP 1996 Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9
3. Hassan MI, Kassim SK, Saeda L, Laban M, Khalifa A 1999 Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-α (TNF-α) release from ovarian tissue. Anticancer Res 19:5657-5662
4. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR 1993 Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91:2194-2206
5. Takeyama H, Wakamiya N, Hara C, Arthur K, Niloff J, Kufe D, Sakarai K, Spriggs D 1991 Tumor necrosis factor expression by human ovarian carcinoma in vivo. Cancer Res 51:4476-4480
6. Spriggs DR, Imamura K, Rodriguez C, Sariban E, Kufe DW 1988 Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest 81:455-460
7. Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC 1993 Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res 53:1939-1944
8. Wu S, Meeker WA, Wiener JR, Berchuck A, Bast RC, Boyer CM 1994 Transfection of ovarian cancer cells with tumor necrosis factor-α (TNF-α) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-α. Gynecol Oncol 53:59-63
9. Massad LS, Mutch DG, Kao MS, Powell CB, Collins JL 1991 Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor α and interferon gamma in cell lines derived from gynecological malignancies. Cancer Immunol Immunother 33:183-188
10. Fiers W 1991 Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212
11. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W 1990 Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-359
12. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG 1990 A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023
13. Boldin MP, Goncharov TM, Goltsev YV, Wallach D 1996 Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-815
14. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM 1996 FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961-4965
15. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME 1997 FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794-2804
16. Yang X, Chang HY, Baltimore D 1998 Autoproteolytic activation of procaspases by oligomerization. Mol Cell 1:319-325
17. Kruppa G, Thoma B, Machleidt T, Wiegmann K, Kronke M 1992 Inhibition of tumor necrosis factor (TNF)-mediated NF-κB activation by selective blockade of the human 55-kDa TNF receptor. J Immunol 148:3152-3157
18. Laegreid A, Medvedev A, Nonstad U, Bombara MP, Ranges G, Sundan A, Espevik T 1994 Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor κB and induction of human cytomegalovirus enhancer. J Biol Chem 269:7785-7791
19. Rothe M, Sarma V, Dixit VM, Goeddel DV 1995 TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427
20. Rothe M, Wong SC, Henzel WJ, Goeddel DV 1994 A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692
21. Berberich I, Shu GL, Clark EA 1994 Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J Immunol 153:4357-4366
22. Sarma V, Lin Z, Clark L, Rust BM, Tewari M, Noelle RJ, Dixit VM 1995 Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem 270:12343-12346
23. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C 1996 A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 271:18068-18073
24. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, Soares M, Grey ST, Bach FH 1998 A20 inhibits NF-κB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91:2249-2258
25. Hu X, Yee E, Harlan JM, Wong F, Karsan A 1998 Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 92:2759-2765
26. Catz SD, Johnson JL 2001 Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 20:7342-7351
27. Zong WX, Edelstein LC, Chen C, Bash J, Gélinas C 1999 The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev 13:382-387
28. Erl W, Hansson GK, de Martin R, Draude G, Weber KS, Weber C 1999 Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 84:668-677
29. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J 1998 Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 188:211-216
30. Kreuz S, Siegmund D, Scheurich P, Wajant H 2001 NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21:3964-3973
31. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J 2001 NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299-5305
32. Xiao CW, Asselin E, Tsang BK 2002 Nuclear factor κB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor α-induced apoptosis in rat granulosa cells. Biol Reprod 67:436-441
33. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J 1997 Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195
34. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J 1997 Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521
35. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM 1997 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 272:17255-17257
36. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D 1997 CASH, a novel caspase homologue with death effector domains. J Biol Chem 272:19641-19644
37. Srinivasula SM, Ahmad M, Lin JH, Poyet JL, Fernandes-Alnemri T, Tsichlis PN, Alnemri ES 1999 CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-κB activation and apoptosis. J Biol Chem 274:17946-17954
38. Shu HB, Halpin DR, Goeddel DV 1997 Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6:751-763
39. Inohara N, Koseki T, Hu Y, Chen S, Nunez G 1997 CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc Natl Acad Sci USA 94:10717-10722
40. Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, Riedel RT, Baskin DG, Schwartz SM, Hood L 1997 MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc Natl Acad Sci USA 94:11333-11338
41. Simmons KR, Caffrey JL, Phillips JL, Abel JHJ, Niswender GD 1976 A simple method for preparing suspensions of luteal cells. Proc Soc Exp Biol Med 152:366-371
42. McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard DW 1996 Inactivation of IκBβ by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol Cell Biol 16:2083-2090
43. Schneiderman D, Kim JM, Senterman M, Tsang BK 1999 Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells. Apoptosis 4:271-282
44. Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG, Tsang BK 2001 Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 142:370-380
45. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B 1975 An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72;3666-3670
46. Old LJ 1985 Tumor necrosis factor (TNF). Science 230:630-632
47. Akiyama Y, Yamaguchi K, Sato T, Abe K 1992 Tumor necrosis factor-α stimulates colony formation by a megakaryoblastic leukemia cell line, CMK. Jpn J Cancer Res 83:989-994
48. Miura K, Teramura M, Hoshino S, Mizoguchi H, Sato T 1992 Stimulatory effect of tumor necrosis factor-α on the growth of CMK, a human megakaryoblastic leukemia cell line. Leuk Res 16:281-285
49. Drexler HG, Zaborski M, Quentmeier H 1997 Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia 11:701-708
50. Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH, Walczak H 2000 Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 60:553-559
51. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ 1998 Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833-2840
52. Wang J, Lobito AA, Shen F, Hornung F, Winoto A, Lenardo MJ 2000 Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 30:155-163
53. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, Hamada H, Nishioka K 2000 Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor α and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules. Arthritis Rheum 43:1106-1114
54. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW 2000 Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633-642
55. Xiao CW, Ash K, Tsang BK 2001 Nuclear factor-κB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor α-induced apoptosis. Endocrinology 142:557-563
56. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K 1996 Bcl-2 down-regulates the activity, of transcription factor NF-κB induced upon apoptosis. J Cell Biol 134:13-23
57. Deveraux Q, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC 1999 Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 18:5242-5251
58. Tartaglia LA, Goeddel DV 1992 Two TNF receptors. Immunol Today 13:151-153
59. Osborn L, Kunkel S, Nabel GJ 1989 Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 86:2336-2340
60. Wiegmann K, Schutze S, Kampen E, Himmler A, Machleidt T, Kronke M 1992 Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 267:17997-18001
61. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV 1993 A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853
62. Smith CA, Farrah T, Goodwin RG 1994 The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962
63. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W 1995 Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913
64. Schneider P, Tschopp J 2000 Apoptosis induced by death receptors. Pharm Acta Helv 74:281-286